Inhibition of Lung Adenocarcinoma Growth by using Oridonin

Abstract

The abnormal activity of the Notch signal pathway is a common manifestation of many cancerous cells. Therefore,
blocking the notch pathway of cancer cells positively affects cancer treatment. Because oridonin directly acts on the
target notch receptor 1-4 cancer cells, inhibiting the Notch signaling pathway can inhibit the growth of cancer cells.